
Vice President, Regulatory Affairs
Posted Oct 2

Posted Oct 2
This is a fully remote position, open to applicants in United States.
β’ Take ownership and lead Loyal's comprehensive regulatory strategy across all ongoing programs, encompassing integrated CMC and clinical regulatory plans from initial development through approval and post-approval lifecycle management.
β’ Provide regulatory insights for portfolio planning, program prioritization, and business development initiatives.
β’ Develop and sustain global regulatory intelligence capabilities, translating agency expectations, guidance, and industry precedents into actionable strategies.
β’ Deliver regulatory updates and risk assessments to executive leadership and the board of directors.
β’ Direct CMC regulatory activities, including strategy for filings, authorship and review of CMC sections, management of post-approval CMC changes, and oversight of manufacturing and CDMO partners.
β’ Collaborate with CMC and Quality leadership on CDMO regulatory readiness, pre-approval inspections, and CMC-related agency interactions.
β’ Lead clinical regulatory efforts, including IND strategy and management, regulatory review of protocols, oversight of study reports, and integration of clinical data into submissions.
β’ Supervise regulatory strategy for pivotal studies, ensuring alignment of study design, endpoints, and agency expectations.
β’ Own the strategy and execution for approval submissions across CMC, Clinical, and Quality, ensuring submission-ready packages meet agency expectations and eCTD standards.
β’ Act as Loyal's primary point of contact with global regulatory agencies for pre-submission meetings, formal submissions, and ongoing communications.
β’ Manage post-approval obligations, such as periodic reports, labeling updates, commitments for post-approval studies, and CMC variation filings.
β’ Develop and oversee labeling strategy and content throughout the product lifecycle.
β’ Establish and manage the regulatory information management infrastructure, eCTD publishing capabilities, and submission archiving standards.
β’ Build and lead a high-performing regulatory organization encompassing CMC regulatory, clinical regulatory, submissions management, labeling, and regulatory operations.
β’ Create and scale regulatory governance frameworks and procedural documents for submissions, agency meetings, labeling reviews, and regulatory decisions.
β’ Serve as the independent regulatory authority, escalating risks and compliance issues to executives.
β’ Promote regulatory excellence and proactive risk management throughout the organization.
β’ A Ph.D. in Pharmaceutical Sciences, Chemical Engineering, Chemistry, or a related scientific field, or equivalent biotechnical experience and expertise, is required.
β’ 18+ years of progressive regulatory affairs experience in pharmaceutical or biotech settings, with at least 10 years in senior regulatory leadership roles within sponsor organizations.
β’ Strong background in CMC regulatory affairs with extensive expertise in small molecule drug development, including OSD formulation, regulatory strategy for manufacturing processes, CMC section authorship, and management of post-approval changes.
β’ Proven experience in leading regulatory teams across both CMC and clinical regulatory functions.
β’ Established history of successful interactions with regulatory agencies, including pre-submission meetings, formal correspondence, and advisory engagements throughout the product development lifecycle.
β’ Demonstrated experience in leading at least one product to regulatory approval, including NDA, MAA, or equivalent submission leadership.
β’ Required experience in post-approval regulatory activities, such as CMC change management, labeling updates, periodic safety and annual reports, and commitments for post-approval studies.
β’ Experience in building and scaling regulatory organizations in startup or high-growth environments.
β’ Strong working knowledge of ICH guidelines and regulatory requirements across relevant global markets.
β’ Executive presence with the capability to act as the company's primary regulatory authority and represent Loyal credibly with regulatory agencies and senior external stakeholders.
β’ Primary experience in human health pharmaceutical or biotech environments is strongly preferred; experience in animal health is a plus.
β’ Familiarity with FDA CVM regulations and the veterinary drug approval pathway (NADA/ANADA), or the ability to quickly develop expertise in a novel regulatory framework.
β’ Experience in filing with and engaging with the EMA and major Asian regulatory agencies (PMDA, NMPA, or equivalents) is a significant advantage.
β’ Experience in supporting first commercial launches and establishing post-approval regulatory infrastructure in a company transitioning toward commercialization.
β’ Understanding of eCTD submission standards and regulatory operations best practices for late-stage development companies.
β’ Experience leading organizations through significant growth, transformation, or milestones in regulatory events.
β’ A strong systems thinking mindset with a disciplined, risk-based approach to regulatory strategy and decision-making.
β’ Comprehensive health insurance coverage β medical, dental, and vision β for you and your dependents.
β’ $1,000 stipend for home office equipment.
β’ Annual learning budget of $1,200 for books, courses, and additional educational resources.
β’ Monthly wellness budget of $250 for gym memberships, cleaners, spa services, food, and more.
β’ All 3-day weekends are extended to 4-day weekends.
β’ Unlimited vacation time along with paid holidays.
β’ Paw-ternity leave β adopt a dog and receive a day off to spend with your new family member.
β’ Competitive salary.
β’ Company equity options granted to new hires.
Syner-G BioPharma Group
Allianz
Pfizer
Allianz
Get handpicked remote jobs straight to your inbox weekly.